Sun Pharmaceutical Industries announces a USD 100 million investment to commercialize new speciality products, strengthening ...

The healthcare business is of Rs 4.35 lakh crore. She did bachelor's in Economics from the Wharton School of the University ...

Several Indian pharmaceutical companies are ushering in the next generation of their promoter families to take over the reins ...

Sun Pharma plans a $100 million investment to commercialize innovative products, including Unloxcyt and Leqselvi, aiming for ...

Sun Pharmaceutical Industries has lined up a USD 100 million investment to commercialise innovative products in the current ...

Dilip Shanghvi is not one for flamboyant statements or headline-grabbing moves. Yet, over the decades, the soft-spoken Chairman & Managing Director of Sun Pharma has turned the company from a ...

The company projects revenue growth of mid- to high single digits in FY26 compared with an 8.5% increase in FY25 ...

In his 42-year journey of building Sun Pharma from the ground up, there is only one thing Dilip Shanghvi would do differently. “Sometimes I would have got angry… That I wouldn’t have wanted ...

Sun Pharma to invest $100 million in speciality products, targeting growth in innovative treatments for the future.

Vidhi Shanghvi is the daughter of Dilip Shanghvi. She plays an important role in Sun Pharmaceutical Industries along with brother Aalok Shanghvi. The healthcare business is of Rs 4.35 lakh crore.